ALFA Finder| Value | ₹4.00 Cr |
|---|---|
| Execution period | 2 Years |
BSE filing, BSE: 542910. Summary written from the filing by ALFA Finder's alert engine.
Valencia Nutrition Ltd: key numbers
- Share price
- ₹59.40
- Market cap
- ₹117.8 Cr
- Revenue (annual)
- ₹7.88 Cr
- Net profit (annual)
- ₹1.09 Cr
- P/E (TTM)
- 107.8×Sector 29.0×
- Promoter holding
- 66.92%+2.74% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Valencia Nutrition Ltd
All →Valencia Nutrition Board Meeting Date
Valencia Nutrition scheduled a board meeting for November 14, 2026 to consider half-year unaudited standalone and consolidated results. The trading window stays closed until 48 hours after results are declared.
Valencia Nutrition Convertible Warrants
Valencia Nutrition Ltd reported the lapse of 23,90,000 convertible warrants following the expiry of the conversion period. An upfront amount of ₹2.39 Crore was forfeited.
- Value
- ₹2.39 Cr
Valencia Nutrition Other Announcement
Valencia Nutrition Ltd has submitted a compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026.
Valencia Nutrition Other Announcement
Valencia Nutrition Ltd directors and relatives disclosed multiple market transactions. Hiren Rajendra Jain and Parthavi Hiren Jain purchased shares, while Jay Jatin Shah sold equity.
- Value
- ₹0.39 Cr
Valencia Nutrition Other Announcement
Mr. Jay Jatin Shah, WTD & CFO of Valencia Nutrition Limited, disposed of 42,000 equity shares via open market transactions totaling Rs. 0.18 Crore.
- Value
- ₹0.25 Cr
Valencia Nutrition Merger & Restructuring Worth ₹0.01 Cr
Valencia Nutrition Limited incorporated a new subsidiary, Valencia Can Beverages Private Limited, on September 29, 2026. The company holds a 75% stake following a Rs. 0.01 Crore subscription.
- Value
- ₹0.01 Cr
Other product launch announcements
All →Jeena Sikho Lifecare Product Launch
Jeena Sikho Lifecare launched ten new Ayurvedic healthcare products in the domestic market on November 11, 2026. The filing gives product-wise details under SEBI product-launch disclosure rules.
HCL Technologies Product Launch
HCLTech launched a pre-configured semiconductor PLM solution built on PTC Windchill, developed in collaboration with PTC. The release states no contract value or deal size, and the launch is a new product offering.
Morepen Laboratories Product Launch
Morepen launched Desloratadine Tablets USP 5 mg, its first US prescription generic, through subsidiary Morepen Bio Inc. It also filed a Sitagliptin ANDA with the US FDA.
AstraZeneca Pharma India Product Launch
AstraZeneca Pharma India will launch Datverzo, Datopotamab Deruxtecan, in India in November 2026. The drug holds DCGI import and market permission for HR-positive, HER2-negative breast cancer.
Raama Finance Product Launch
Raama Finance launched 'Rupya Lelo', a digital lending platform offering instant personal loans, on October 6, 2026. The product is available only in India, and no loan amount or financial figure is disclosed.
Puravankara Product Launch
Puravankara will launch the residential project Purva Cityspire Phases 1, 2 and 3 in Ernakulam on 15 November 2026. The project is RERA-registered and is being developed by two wholly owned subsidiaries.